🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vinayak Palve

Moffitt Cancer Center

ORCID: 0000-0002-8221-5018
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity”.

Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Cancer Immunology Research(2021)10.1158/2326-6066.cir-20-0905
N/A
0DataRank · unranked
48 citations

Zhihua Chen, Jiannong Li, Eslam Mohamed, Michael A. Davies, Inna Smalley +15 more

The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors

Cell chemical biology(2021)10.1016/j.chembiol.2021.07.008
N/A
0DataRank · unranked
38 citations

Claire E. Knezevic, Daniel S. Bejan, Yunting Luo, Xueli Li, Silvia Novakova +10 more

Referee report. For: Silencing of Carboxypeptidase E expression inhibits proliferation and invasion of Panc-1 pancreatic cancer cells [version 2; peer review: 2 approved]

Faculty of 1000 Research Ltd(2022)10.5256/f1000research.121874.r136270
N/A
0DataRank · unranked
0 citations

Vinayak Palve

Data from Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

(2023)10.1158/2326-6066.c.6550279.v1
N/A
0DataRank · unranked
0 citations

Zhihua Chen, Jiannong Li, Eslam Mohamed, Michael A. Davies, Inna Smalley +15 more